HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lili Ji Selected Research

Biological Products

1/2021LncRNA CASC2 targets CAV1 by competitively binding with microRNA-194-5p to inhibit neonatal lung injury.
1/2018Natural product andrographolide alleviated APAP-induced liver fibrosis by activating Nrf2 antioxidant pathway.
8/2017Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA.
10/2016Expression of far upstream element binding protein 1 in B‑cell non‑Hodgkin lymphoma is correlated with tumor growth and cell‑adhesion mediated drug resistance.
7/2015Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.
7/2015Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas.
8/2014Expression of small glutamine-rich TPR-containing protein A (SGTA) in Non-Hodgkin's Lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lili Ji Research Topics

Disease

19Neoplasms (Cancer)
01/2021 - 02/2003
16Inflammation (Inflammations)
11/2021 - 10/2007
15Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 01/2012
11Diabetic Retinopathy (Retinopathy, Diabetic)
03/2022 - 01/2015
9Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 04/2014
8Hepatocellular Carcinoma (Hepatoma)
10/2020 - 10/2007
5Acute Liver Failure (Fulminant Hepatic Failure)
12/2021 - 02/2016
5Pain (Aches)
11/2021 - 01/2018
5Hypoxia (Hypoxemia)
01/2020 - 09/2012
5Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
12/2019 - 09/2016
4Fibrosis (Cirrhosis)
10/2021 - 05/2018
3Non-alcoholic Fatty Liver Disease
02/2022 - 10/2020
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 08/2013
3Infections
04/2021 - 10/2007
3Breast Neoplasms (Breast Cancer)
10/2020 - 08/2019
3Hyperglycemia
11/2019 - 01/2019
3Chemical and Drug Induced Liver Injury
01/2018 - 02/2016
3Lymphoma (Lymphomas)
10/2016 - 08/2014
2Bacterial Infections (Bacterial Infection)
01/2021 - 10/2015
2Multiple Myeloma
10/2020 - 07/2015
2Thyroid Diseases (Thyroid Disease)
01/2019 - 10/2018
2Wounds and Injuries (Trauma)
08/2018 - 09/2012
2Neoplasm Metastasis (Metastasis)
08/2017 - 09/2015
2Ascites
01/2017 - 09/2016
2Lung Neoplasms (Lung Cancer)
03/2016 - 01/2013
1Frailty
10/2022
1Mitochondrial Diseases (Mitochondrial Disease)
02/2022
1Necrosis
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Cholecystolithiasis
01/2022
1COVID-19
01/2022
1Rheumatoid Arthritis
11/2021
1Experimental Arthritis
11/2021

Drug/Important Bio-Agent (IBA)

13Inosine Triphosphate (ITP)IBA
01/2022 - 01/2012
10Acetaminophen (Paracetamol)FDA LinkGeneric
10/2022 - 08/2015
10andrographolideIBA
01/2018 - 10/2007
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 09/2012
9Retinaldehyde (Retinal)IBA
01/2021 - 01/2015
7Chlorogenic AcidIBA
03/2022 - 08/2015
7Biological ProductsIBA
01/2021 - 08/2014
6Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2015
5Messenger RNA (mRNA)IBA
10/2020 - 09/2012
5AntioxidantsIBA
08/2019 - 09/2016
5Dexamethasone (Maxidex)FDA LinkGeneric
08/2019 - 12/2012
4diosbulbin BIBA
10/2022 - 04/2015
4CytokinesIBA
02/2021 - 07/2014
4MonocrotalineIBA
12/2019 - 09/2016
4Pharmaceutical PreparationsIBA
08/2019 - 04/2017
3Carbon Tetrachloride (Tetrachloromethane)IBA
10/2022 - 05/2018
3Methionine (L-Methionine)FDA Link
02/2022 - 10/2020
3Choline (Choline Chloride)IBA
02/2022 - 10/2020
3LipidsIBA
01/2022 - 10/2020
3Long Noncoding RNAIBA
01/2021 - 01/2018
3LactonesIBA
07/2014 - 10/2007
3DiterpenesIBA
07/2014 - 10/2007
2Small Interfering RNA (siRNA)IBA
02/2022 - 09/2016
2VaccinesIBA
01/2022 - 06/2015
2CollagenIBA
01/2022 - 01/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 01/2021
2QuercetinIBA
11/2021 - 01/2017
2InterleukinsIBA
11/2021 - 02/2021
2Hydroxyproline (4 Hydroxyproline)IBA
10/2020 - 01/2019
2Analgesics (Analgesic Drugs)IBA
07/2020 - 01/2018
2sappanone AIBA
01/2020 - 01/2020
2liquiritigeninIBA
12/2019 - 08/2019
2liquiritinIBA
12/2019 - 08/2019
2ErianinIBA
11/2019 - 09/2016
2Catechin (Z 7300)IBA
01/2019 - 04/2018
2Claudin-1IBA
12/2018 - 01/2015
2MicroRNAs (MicroRNA)IBA
08/2017 - 08/2016
2Transaminases (Aminotransferases)IBA
01/2017 - 09/2016
2Streptozocin (Streptozotocin)FDA Link
08/2016 - 04/2015
2Interleukin-10 (Interleukin 10)IBA
03/2015 - 12/2012
2multidrug resistance-associated protein 1IBA
01/2014 - 01/2013
2Glutathione (Reduced Glutathione)IBA
08/2011 - 01/2009
2JNK Mitogen-Activated Protein KinasesIBA
01/2009 - 10/2007
1SilymarinIBA
10/2022
1HMGB1 Protein (HMG1)IBA
10/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022
1isotoosendaninIBA
01/2022
1toosendaninIBA
01/2022
1Phe Transfer RNAIBA
01/2022
1Transfer RNA (tRNA)IBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Capsules (Microcapsules)IBA
11/2021
1Butylated Hydroxyanisole (BHA)IBA
11/2021
1Cell Adhesion Molecule-1IBA
11/2021
1kaempferolIBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
11/2021
1ChemokinesIBA
11/2021
1isoliquiritigenin (GU 17)IBA
11/2021
1AcidsIBA
11/2021
1benzoylhypaconineIBA
11/2021

Therapy/Procedure

5Therapeutics
08/2020 - 12/2012
4Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021 - 01/2019
3Activities of Daily Living (ADL)
10/2022 - 08/2020
2Intraperitoneal Injections
01/2019 - 05/2018
2Drug Therapy (Chemotherapy)
01/2019 - 07/2015
1Ligation
10/2022
1Meridians (Jing Luo)
11/2021